MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 27 filers reported holding MOLECULIN BIOTECH INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $414 | -26.1% | 968 | 0.0% | 0.00% | – |
Q2 2023 | $560 | -39.8% | 968 | 0.0% | 0.00% | – |
Q1 2023 | $930 | -31.3% | 968 | 0.0% | 0.00% | – |
Q4 2022 | $1,354 | -66.2% | 968 | -76.4% | 0.00% | – |
Q3 2022 | $4,000 | -33.3% | 4,100 | +3.7% | 0.00% | – |
Q2 2022 | $6,000 | -14.3% | 3,952 | -6.6% | 0.00% | – |
Q1 2022 | $7,000 | +600.0% | 4,233 | +428.5% | 0.00% | – |
Q4 2021 | $1,000 | -50.0% | 801 | 0.0% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 801 | 0.0% | 0.00% | – |
Q2 2021 | $3,000 | 0.0% | 801 | 0.0% | 0.00% | – |
Q1 2021 | $3,000 | – | 801 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 1,036,853 | $1,099,064 | 0.41% |
JMAC ENTERPRISES LLC | 13,132 | $13,920 | 0.00% |
Virtu Financial LLC | 13,791 | $15 | 0.00% |
Sigma Planning Corp | 57,500 | $60,950 | 0.00% |
VANGUARD GROUP INC | 1,080,122 | $1,144,930 | 0.00% |
UBS Group AG | 11,243 | $11,918 | 0.00% |
MASSMUTUAL TRUST CO FSB/ADV | 167 | $0 | 0.00% |
OSAIC HOLDINGS, INC. | 968 | $1,354 | 0.00% |
FMR LLC | 2 | $2 | 0.00% |
BANK OF AMERICA CORP /DE/ | 6,683 | $7,084 | 0.00% |